Osteopontin: Possible role in prostate cancer progression

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 2271-2277

  Thalmann, George N ^a,d   Sikes, R A ^b   Devoll, R E ^c   Kiefer, J A ^c   Markwalder, R ^a   Klima, I ^a   Farach Carson, C M ^c,e   Studer, U E ^a   Chung, L W K ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF BERN   (Switzerland)

^e UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER GROWTH; CARCINOGENESIS; GROWTH REGULATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

ANIMALS; BLOTTING, WESTERN; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DISEASE PROGRESSION; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; OSTEOPONTIN; PROSTATIC NEOPLASMS; RATS; RNA; SIALOGLYCOPROTEINS;

EID: 0032784057     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Gleave, M. E., Hsieh, J. T., von Eschenbach, A. C., and Chung, L. W. K. Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J. Urol., 147: 1151-1159, 1992
2. Wu, H. C., Hsieh, J. T., Gleave, M. E., Brown, N. M., Pathak, S., and Chung, L. W. K. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int. J. Cancer, 57: 406-412, 1994.
3. Thalmann, G. N., Anezinis, P. A., Chang, S. M., Zhau, H. E., Kim, E. E., Hopwood, V. L., Pathak, S., von Eschenbach, A. C., and Chung, L. W. K. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res., 54: 2577-2581, 1994.
4. Gleave, M. E., Hsieh, J. T., Gao, C. A., von Eschenbach, A. C., and Chung, L. W. K. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res., 51: 3753-3761, 1991.
5. Chackal-Roy, M., Niemeyer, C., Moore, M., and Zetter, B. R. Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J. Clin. Invest., 84: 43-50, 1989.
6. Clark, E. A., and Brugge, J. S. Integrins and signal transduction pathways: the road taken. Science (Washington DC), 268: 233-239, 1995.
7. Varner, J. A., and Cheresh, D. A. Integrins and cancer. Curr. Opin. Cell Biol., 8: 724-730, 1996.
8. Butler, W. T. The nature and significance of osteopontin. Conn. Tissue Res., 23: 123-136, 1989.
9. Young, M. F., Ibaraki, K., Kerr, J. M., and Heegaard, A. M. Molecular and cellular biology of the major noncollagenous proteins in bone. In: M. Noda (ed.), Cellular and Molecular Biology of Bone, pp. 191-234. New York: Academic Press, 1993.
10. Weber, G. F., Ashkar, S., Glimcher, M. J., and Cantor, H. Receptor-ligand interaction between DC44 and osteopontin (Eta-1). Science (Washington DC), 271: 509-512, 1996.
11. Brown, L. F., Papadopoulos-Sergiou, A., Berse, B., Manseau, E. J., Taognazzi, K., Perruzzi, C. A., Dvorak, H. F., and Senger, D. J. Osteopontin expression and distribution in human carcinomas. Am. J. Pathol., 145: 610-623, 1994.
12. Sung, V., Gilles, C., Murray, A., Clarke, R., Aaron, A. D., Azumi, N., and Thompson, E. W. The LCC 15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype. Exp. Cell. Res., 241: 273-284, 1998.
13. Ue, T., Yokozaki, H., Kitadi, Y., Yamamoto, S., Yasui, W., Ishikawa, T., and Tahara, E. Co-expression of osteopontin and CD44 v9 in gastric cancer. Int. J. Cancer, 79: 127-132, 1998.
14. Senger, D. R., Perruzzi, C. A., and Papadopoulos, A. Elevated expression of secreted phosphoprotein I (Osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Res., 9: 1291-1299, 1989.
15. Senger, D. R., Perruzzi, C. A., Gracey, C. F., Papadopoulos, A., and Tenen, D. G. Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res., 48: 5770-5774, 1988.
16. Behrend, E. I., Craig, A. M., Wilson, S. M., Denhardt, D. T., and Chambers, A. F. Reduced malignancy of ray-transformed NIH 3T3 cells expressing antisense osteopontin RNA. Cancer Res., 54: 832-837, 1994.
17. Casson, A. G., Wilson, S. M., McCart, J. A., O'Malley, F. P., Ozelik, H., Tsao, M. S., and Chambers, A. F. Ras-mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer. Int. J. Cancer, 72: 739-745, 1997.
18. Thalmann, G. N., Anezinis, P., Devoll, R. E., Farach-Carson, C. M., and Chung, L. W. K. Experimental approaches to skeletal metastasis of human prostate cancer. In: D. Raghavan, H. I. Scher, S. A. Leibel, and P. H. Lange (eds.), Principles and Practice of Genitourinary Oncology, pp. 409-416. Philadelphia: Lippincott-Raven Publishers, 1997.
19. Horoszewicz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809-1818, 1983.
20. Chang, S. M., and Chung, L. W. K. Interaction between prostatic fibroblast and epithelial cells in culture: role of androgen. Endocrinology, 725: 2719-2727, 1989.
21. Farach-Carson, M. C., Wright, G. C., and Butler, W. T. Improved binding of acidic bone matrix proteins to cationized filters during solid phase assays. Bone Mineral, 16: 1-9, 1992.
22. Chung, L. W. K., Li, W., Cleave, M. E., Hsieh, J. T., Wu, H. C., Sikes, R. A., Zhau, H. E., Bandyk, M. G., Logothetis, C. J., and Rubin, J. S. Human prostate cancer model: roles of growth factors and extracellular matrices. J. Cell. Biochem., 16H (Suppl.): 99-105, 1992.
23. Janik, P., Briand, P., and Hartman, N. R. The effect of estroneprogesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res., 35: 3698-3704, 1975.
24. Oates, A. J., Barraclough, R., and Rudland, P. S. The role of osteopontin in tumorigenesis and metastasis. Invasion Metastasis, 17: 1-15, 1997.
25. Gao, A. C., Lou, W., Dong, J. T., and Isaacs, J. T. CD44 is a metastasis suppressor gene for prostatic cancer located on human chromosome 11p13. Cancer Res., 57: 846-849, 1997.
26. Elgavish, A., Prince, C., Chang, P. L., Lloyd, K., Lindsey, R., and Reed, R. Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro. Prostate, 35: 83-94, 1998.
27. Harris, S. E., Harris, M. A., Mahy, P., Wozney, J., Feng, J. Q., and Mundy, G. R. Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells. Prostate, 24: 204-211, 1994.
28. Waltregny, D., Bellahcène, A., Van Riet, I., Fisher, L. W., Young, M., Fernandez, P., Dewé, W., de Levai, J., and Castronovo, V. Prognostic value of bone sialoprotein expression in human clinically localized prostate cancer. J. Natl. Cancer Inst., 90: 1000-1008, 1998.